Tag

Healthcare Associated Infections

All articles tagged with #healthcare associated infections

health1 month ago•6 min saved

Washington Faces Spread of Drug-Resistant Candida Auris

A drug-resistant yeast called Candida auris is spreading across the United States, including Washington state, with more than 4,500 cases nationwide in 2026 and at least a dozen WA infections. It can cause everything from shallow skin infections to life-threatening bloodstream infections and is often resistant to antifungal drugs. The infection mainly hits hospitalized patients with invasive medical devices and those with weakened immune systems, with invasive infections carrying a 30%–60% mortality rate. Treatment usually requires multiple antifungal drugs. Preventing spread relies on strict infection-control in healthcare settings—hand hygiene, patient isolation, room disinfection, and use of gloves and gowns—while home precautions emphasize regular handwashing and careful care of any invasive medical devices.

via Tacoma News Tribune|

#antifungal-treatment #candida-auris #drug-resistant-fungus

health1 month ago•13 min saved

Drug-resistant Candida auris resurges nationwide, reaching Maryland

A drug-resistant fungus, Candida auris, is spreading across the United States, including Maryland; officials say most people are not at high risk, but its resistance to many antifungal medicines creates challenges for hospitals and underscores the need for vigilant surveillance.

via Baltimore Sun|

#antifungal-resistance #candida-auris #cdc

health2 months ago•5 min saved

Drug-Resistant Candida Auris Spreads Across the U.S., Targeting the Vulnerable

A drug-resistant fungus, Candida auris, is spreading in the United States with 3,437 clinical cases this year across 27 states (and 6,304 in 2024). It mainly threatens patients with severe underlying illnesses and invasive devices, and can be carried as colonization without symptoms. Transmission occurs via direct contact or contaminated equipment, not casual contact or airborne spread. Increased screening and better detection mean more cases are found, but eradicating the fungus is unlikely; strict cleaning and infection-control practices in hospitals and long-term care facilities can reduce spread.

via Hartford Courant|

#antimicrobial-resistance #candida-auris #fungal-infections

health2 months ago•201 min saved

Hospitals on alert as Candida auris spreads and resists treatment

Candida auris, a drug-resistant yeast that can persist on surfaces, is spreading in U.S. healthcare facilities. The CDC reported 3,437 clinical cases across 27 states as of July 25, 2026, with last year totaling 4,290, highlighting it as a critical public health threat. It can colonize skin or cause serious infections such as bloodstream infections that may lead to sepsis, especially in patients with underlying conditions. Transmission occurs through contact with contaminated objects and people, and it can resist common cleaning agents, complicating elimination in hospitals and nursing facilities. Detection has increased due to targeted screening, but preventing spread relies on strict infection-control measures, diligent environmental cleaning, hand hygiene, and isolating affected patients; treatment options are limited and depend on the strain.

via CNN|

#antifungal-resistance #candida-auris #cdc

health2 months ago•3 min saved

CDC Warns: Drug-Resistant Candida Auris Spreads to 23 States

Candida auris, a drug-resistant fungus, has spread to 23 states with more than 3,000 cases in 2026 (3,130 reported by July 18). It mainly threatens people with serious underlying conditions and is difficult to treat due to multi-drug resistance. Transmission occurs in healthcare settings via direct contact, contaminated surfaces, or medical equipment; airborne spread is not believed to occur. Early detection, patient screening, and strict infection-control measures are essential to preventing outbreaks.

via WCVB|

#candida-auris #cdc #drug-resistant

health2 months ago•47 min saved

Candida auris detected across 27 states: key facts for the public

As of the week ending July 25, 2026, 3,437 cases of Candida auris have been identified across 27 states (California leading with 873, followed by Texas with 433 and Tennessee with 283), and the number of cases continues to rise each year, though the rate of increase has slowed since 2022. C. auris is a drug‑resistant yeast that can cause infections ranging from skin infections to life-threatening bloodstream infections in very ill patients in healthcare settings, and it can persist on surfaces. Many strains are resistant to fluconazole, with some showing resistance to amphotericin B and echinocandins, and the mortality rate is estimated between 30% and 60%. Those most at risk include immunocompromised individuals and patients with invasive devices in hospitals or nursing homes.

via Yahoo|

#antifungal-resistance #candida-auris #cdc

health2 months ago•25 min saved

Drug-resistant fungus Candida auris expands across the U.S., including New Jersey

A drug-resistant fungus, Candida auris, is spreading across 23 states with more than 3,000 cases this year, mostly in hospitals and nursing homes. The infection can be hard to spot due to nonspecific symptoms, may survive on surfaces for weeks, and has a mortality rate of 30–60%. New Jersey has 166 cases, while Texas leads with 706; health officials warn Candida auris is an urgent antimicrobial-resistance threat identified by the CDC.

via New York Post|

#antimicrobial-resistance #candida-auris #health

health2 months ago•3 min saved

Candida auris cases reach 3,130 in 23 states, CDC reports

The CDC reports 3,130 cases of Candida auris across 23 states as of July 18, with Texas leading (706), followed by Michigan (503) and Illinois (366). While yearly case counts rise, the growth rate is slowing. C. auris is a yeast that can cause severe, hard‑to‑treat infections in very ill patients in healthcare settings and can persist on surfaces for long periods. Many strains are resistant to common antifungals; echinocandins are usually effective, though resistance varies. Mortality is estimated at 30%–60%, but deaths are often complicated by underlying illnesses.

via ABC7 Chicago|

#antifungal-resistance #candida-auris #cdc

health3 months ago•381 min saved

Drug-Resistant Candida auris Surges in U.S. Healthcare Settings

A CDC-led report finds that Candida auris, a drug-resistant yeast, is continuing to spread in U.S. healthcare facilities, with 13,507 cases reported from 2022–2024 and cases in more than half the states. Most infections occur in men over 45 in hospitals or long-term care facilities; the fungus can colonize skin and persist on surfaces, complicating outbreak control. It is consistently resistant to fluconazole and increasingly hard to treat with other antifungals, leaving limited options. Some experts suggest climate-related heat could enable the organism’s adaptation, highlighting the ongoing need for stringent infection prevention and disinfection protocols.

via NBC News|

#antifungal-resistance #candida-auris #cdc